Skip to content
Agentic OS
Menu

Intelligence / Healthtech / Device Recalls / Nipro Renal Soultions USA, Corporation

QualityClass II recall16 Sept 2026

Nipro Renal Soultions USA, Corporation

16 Sept 2026: Class II recall · MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X)). Recorded in the openFDA device enforcement reports.

View the source record

Reported
16 Sept 2026
Recall Class
Class II
Product
MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))
Reason
Hemodialysis concentrates contain high endotoxin levels
Country
United States
Status
Ongoing
Reference
Z-3134-2026
Location
Lewisberry, PA
What this signal means

A recall puts quality, regulatory, field service and communications under pressure at once.

  1. Class II leads with 660 of 741, then Class I (68).
  2. 235 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Nipro Renal Soultions USA, Corporation

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this quality signal, for your approval.

Start free

Across AOS Research

Other records for Nipro Renal Soultions USA, Corporation in our registers.

More in Class II

Device Recalls

See all

Source: openFDA device enforcement reports, data to 18 Nov 2026. Device recalls classified by FDA, by report date. Class I is the most serious. AOS shows what the public record says; it does not verify or endorse the company.